Amgen (AMGN) Operating Income (2009 - 2026)
Amgen's Operating Income came in at $3.71 billion for Q3 2026, up 46.9% from $2.53 billion a year earlier and up 5.6% from the prior quarter.
Amgen (AMGN) Operating Income (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Amgen reported Operating Income of $12.61 billion, up 45.4% year-over-year; for FY2025, it was $9.08 billion, up 25.1% from FY2024.
- Operating Income carries a five-year compound annual growth rate of -0.1% (FY2020 to FY2025).
- Going back by year, Operating Income was $7.26 billion in FY2024 (-8.1%), $7.9 billion in FY2023 (-17.4%), $9.57 billion in FY2022 (+25.2%) and $7.64 billion in FY2021 (-16.4%).
- The Q3 2026 figure represents the highest quarterly Operating Income in data going back to Q1 2009.
- Year-over-year, Operating Income has increased for nine consecutive quarters, with growth averaging 48.3% over the last eight quarters.
- The fastest year-over-year change in Operating Income over five years came in Q2 2022 (growth of 162.8%), and the weakest in Q1 2024 (a decline of 48.4%).
- Business Quant data shows AMGN's Operating Income at $3.51 billion (Q2 2026), $2.67 billion (Q1 2026) and $2.72 billion (Q4 2025) in the three quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 712.90 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 3.71 Bn |
| Jun 30, 2026 | 3.51 Bn |
| Mar 31, 2026 | 2.67 Bn |
| Dec 31, 2025 | 2.72 Bn |
| Sep 30, 2025 | 2.53 Bn |
| Jun 30, 2025 | 2.66 Bn |
| Mar 31, 2025 | 1.18 Bn |
| Dec 31, 2024 | 2.31 Bn |
| Sep 30, 2024 | 2.05 Bn |
| Jun 30, 2024 | 1.91 Bn |
| Mar 31, 2024 | 991.00 Mn |
| Dec 31, 2023 | 1.27 Bn |
| Sep 30, 2023 | 2.02 Bn |
| Jun 30, 2023 | 2.68 Bn |
| Mar 31, 2023 | 1.92 Bn |
| Dec 31, 2022 | 2.23 Bn |
| Sep 30, 2022 | 2.66 Bn |
| Jun 30, 2022 | 2.18 Bn |
| Mar 31, 2022 | 2.50 Bn |
| Dec 31, 2021 | 2.30 Bn |
Amgen Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=AMGN&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();